Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

By Alba Emilio   Ruiz-Borrego Manuel   Margelí Mireia   Rodríguez-Lescure Álvaro   Sánchez-Rovira Pedro   Ruiz Amparo   Mel-Lorenzo Jose   Ramos-Vázquez Manuel   Ribelles Nuria   Calvo Elisa   Casado Antonio   Márquez Antonia   Vicente David   García-Sáenz José   Martín Miguel  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 169-176

Springer Publishing Company

Access to resources Recommend Favorite

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 987-993

Spandidos Publications

Access to resources Recommend Favorite

Chemotherapy For Metastatic Breast Cancer--When is Enough Enough?

By Stockler M.   Wilcken N.   Coates A.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2147-2148

Elsevier

Access to resources Recommend Favorite

Chemotherapy of Metastatic Breast Cancer: Is more better?

By Jassem Jacek  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 37-42

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy or Endocrine Therapy for Metastatic Breast Cancer?

By Wilcken Nicholas   Hornbuckle Joanne   Ghersi Davina  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 53-56

Springer Publishing Company

Access to resources Recommend Favorite